[3rd generation ABL kinase inhibitor and Philadelphia chromosome positive leukemia]

Rinsho Ketsueki. 2013 Oct;54(10):1682-6.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Clinical Trials as Topic
  • Fusion Proteins, bcr-abl / genetics
  • Humans
  • Imidazoles / chemistry
  • Imidazoles / therapeutic use
  • Leukemia / diagnosis
  • Leukemia / drug therapy*
  • Leukemia / genetics
  • Philadelphia Chromosome / drug effects*
  • Protein Kinase Inhibitors / therapeutic use*
  • Pyridazines / chemistry
  • Pyridazines / therapeutic use

Substances

  • Imidazoles
  • Protein Kinase Inhibitors
  • Pyridazines
  • ponatinib
  • Fusion Proteins, bcr-abl